Skip to main content
Jagsonpal Pharmaceuticals Limited logo

Jagsonpal Pharmaceuticals Limited — Investor Relations & Filings

Ticker · JAGSNPHARM ISIN · INE048B01035 BSE.NS Manufacturing
Filings indexed 1,044 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS JAGSNPHARM

About Jagsonpal Pharmaceuticals Limited

https://www.jagsonpal.com/

Jagsonpal Pharmaceuticals Limited specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company maintains a significant focus on therapeutic segments including gynecology, orthopedics, and pain management. Its product portfolio features established brands in women's healthcare, particularly in the areas of pregnancy care and hormonal therapy, as well as treatments for bone health and inflammatory conditions. The organization leverages its research and development capabilities to introduce specialized formulations that address specific medical needs in its core therapeutic areas. By maintaining an extensive distribution network, the company ensures the accessibility of its products to healthcare professionals and patients, focusing on quality and therapeutic efficacy across its specialized product lines.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2026-05-25 English
Submission of copy of Post Buy Back Public Advertisement related to Buy back of shares of Company.
Transaction in Own Shares Classification · 90% confidence The document is a submission letter to stock exchanges regarding the post buyback public advertisement for the company’s tender‐offer share buyback under SEBI regulations. It relates to the company’s repurchase of its own shares. According to the taxonomy, such announcements about share buyback transactions fall under 'Transaction in Own Shares' (POS).
2026-05-25 English
Centrum Broking Ltd ("Manager to the Buyback") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares ....
Transaction in Own Shares Classification · 90% confidence The document is a formal public announcement filed with the stock exchange and SEBI regarding the post-completion of a share buyback under the Buy-back of Securities Regulations. It describes timing, advertisement publication in newspapers, and is explicitly about the company repurchasing its own shares. This fits the “Transaction in Own Shares” category (POS).
2026-05-25 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation
Board/Management Information Classification · 95% confidence The document is an intimation under SEBI LODR Regulation 30 regarding the resignation of an Independent Director, including details of cessation, disclosures under Schedule III, and enclosures of resignation letters. This clearly constitutes an announcement of a change in the company’s board composition, fitting the Board/Management Information category.
2026-05-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.